Literature DB >> 8473296

Characterization of transferrin-independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake.

R S Inman1, M Wessling-Resnick.   

Abstract

The present study characterizes the transport of nontransferrin (non-Tf) iron by K562 cells. Accumulation of radiolabel by cells incubated with 55Fe-nitrilotriacetate (NTA) is a saturable process that is time and temperature dependent (Ea approximately 20 kcal/mol). Initial rate analysis of iron influx yields values of Vmax = 855 fmol/min/10(6) cells and apparent Km = 0.54 microM. NHCL4 and chloroquine, agents that block cellular acquisition of iron from Tf, do not interfere with assimilation from FeNTA, demonstrating that uptake is truly independent of the Tf-mediated pathway. Furthermore, the inactivation of this transport mechanism by limited proteolytic digestion on ice indicates that specific cell surface proteins are involved. The extent of radiolabel incorporation into heme and ferritin is the same regardless of whether K562 cells acquire iron from 55FeNTA via the cell surface mechanism or from 55Fe-Tf via receptor-mediated endocytosis. Unlike other Tf-independent iron transport pathways that have been described, the K562 cell transport mechanism is not inhibited by divalent cations such as Ni2+, Co2+, or Mn2+. Uptake from 55FeNTA can be blocked by Cu2+ but at concentrations > 1500-fold molar excess. However, Cd2+ is a fairly specific inhibitor of 55Fe uptake by K562 cells (IC50 approximately 50 microM). Additionally, the K562 cell transport mechanism is not Ca2+ dependent and does not appear to be regulated by extracellular iron salts, in contrast to features noted for non-Tf iron uptake by fibroblasts (Sturrock, A., Alexander, J., Lamb, J., Craven, C. M., and Kaplan, J. (1991) J. Biol. Chem. 265, 3139-3145; Kaplan, J., Jordan, I., and Sturrock, A. (1991) J. Biol. Chem. 266, 2997-3004). These unique characteristics of the K562 cell uptake mechanism suggest that multiple transport systems function in Tf-independent iron assimilation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons.

Authors:  Changyi Ji; Daniel J Kosman
Journal:  J Neurochem       Date:  2015-03-10       Impact factor: 5.372

2.  Differing expression of genes involved in non-transferrin iron transport across plasma membrane in various cell types under iron deficiency and excess.

Authors:  Kamila Balusikova; Jitka Neubauerova; Marketa Dostalikova-Cimburova; Jiri Horak; Jan Kovar
Journal:  Mol Cell Biochem       Date:  2008-10-02       Impact factor: 3.396

3.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport.

Authors:  M D Fleming; M A Romano; M A Su; L M Garrick; M D Garrick; N C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

4.  The inability of cells to grow in low iron correlates with increasing activity of their iron regulatory protein (IRP).

Authors:  J Kovár; L C Kühn; V Richardson; C Seiser; K Kriegerbecková; J Musílková
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-09       Impact factor: 2.416

5.  Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators.

Authors:  F Vaillant; J A Larm; G L McMullen; E J Wolvetang; A Lawen
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

6.  Treatment of PC12 cells with nerve growth factor increases iron uptake.

Authors:  J Mwanjewe; B K Hui; M D Coughlin; A K Grover
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver.

Authors:  Hiromi Gunshin; Yuko Fujiwara; Angel O Custodio; Cristina Direnzo; Sylvie Robine; Nancy C Andrews
Journal:  J Clin Invest       Date:  2005-04-21       Impact factor: 14.808

8.  Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake.

Authors:  Herbert A Wetli; Peter D Buckett; Marianne Wessling-Resnick
Journal:  Chem Biol       Date:  2006-09

9.  Mobilferrin is an intermediate in iron transport between transferrin and hemoglobin in K562 cells.

Authors:  M E Conrad; J N Umbreit; E G Moore; D Heiman
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  The mammalian transferrin-independent iron transport system may involve a surface ferrireductase activity.

Authors:  I Jordan; J Kaplan
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.